AbCellera is currently testing the bottom of a key weekly gap near the $2.50 level, a major support area that has historically acted as a launch point for strong reversals. A confirmed breakout above the $6.00 level would signal renewed bullish momentum and open the path toward the $9.89 resistance, which aligns with previous supply zones.
With selling pressure fading and momentum stabilizing, ABCL appears ready for a bounce. The setup offers an excellent risk-to-reward ratio, especially with a well-defined stop-loss at $1.87, allowing traders to manage downside risk while targeting meaningful upside.
AbCellera continues to benefit from long-term biotech innovation tailwinds, including antibody discovery partnerships and expanding pipeline collaborations—fundamental drivers that complement the bullish technical setup.
With selling pressure fading and momentum stabilizing, ABCL appears ready for a bounce. The setup offers an excellent risk-to-reward ratio, especially with a well-defined stop-loss at $1.87, allowing traders to manage downside risk while targeting meaningful upside.
AbCellera continues to benefit from long-term biotech innovation tailwinds, including antibody discovery partnerships and expanding pipeline collaborations—fundamental drivers that complement the bullish technical setup.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.